Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
2006 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
2014
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure
2005
Antimicrobial Lock Solutions for the Prevention of Infections Associated with Intravascular Catheters in Patients Undergoing Hemodialysis: Systematic Review and Meta‐analysis of Randomized, Controlled Trials
2008
The prognostic importance of creatinine clearance after acute myocardial infarction
2002
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community
2002
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials
2007
Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment
2003
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Wound repair and regeneration
2008 StandoutNature
Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality
2004
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Meta-analysis of Hemodialysis Catheter Locking Solutions in the Prevention of Catheter-Related Infection
2008
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population
2008
Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals
2002
Chronic Kidney Disease and Sudden Death: Strategies for Prevention
2004
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
A Randomised Controlled Trial to Compare Intravenous Iron Sucrose and Oral Iron in Treatment of Iron Deficiency Anemia in Pregnancy
2013
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction
2002
Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality
2012
Regulation of PDGF and its receptors in fibrotic diseases
2004
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
2012
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
2012
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
2009
Cardiorenal Syndrome
2008 Standout
Systemic Lupus Erythematosus
2011 Standout
Renal function and risk stratification in acute coronary syndromes
2003
Renal function: the Cinderella of cardiovascular risk profile
2001
Chronic kidney disease: global dimension and perspectives
2013 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease
2002
Emergency Evaluation of Chest Pain in Patients With Advanced Kidney Disease
2002
Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
2012
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly
2003
Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
2005
The basics of epithelial-mesenchymal transition
2009 Standout
Hypoxic induction ofCtgfis directly mediated by Hif-1
2004
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)
2003
The Hallmarks of Aging
2013 Standout
Anaemia in kidney disease: harnessing hypoxia responses for therapy
2015
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations
2003
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Prediabetes: a high-risk state for diabetes development
2012 Standout
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor Prevents Renal Interstitial Fibrosis
2002
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors
2003
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Underuse of Standard Care and Outcome of Patients with Acute Myocardial Infarction and Chronic Renal Insufficiency
2006
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel
2007
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes
2002
Molecular insights into renal interstitial fibrosis.
1996
Myofibroblasts. I. Paracrine cells important in health and disease
1999
A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes
2003
Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency
2002
The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes
2003
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Angiotensin II and Renal Fibrosis
2001
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
2002
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis
2007
Acute kidney injury: a springboard for progression in chronic kidney disease
2010
Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation
2002
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Renal Connective Tissue Growth Factor Induction in Experimental Diabetes Is Prevented by Aminoguanidine
2002
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
2010
Iron Supplementation in Nephrology and Oncology: What Do We Have in Common?
2011
Early role of Fsp1 in epithelial-mesenchymal transformation
1997
Mechanisms of Diabetic Complications
2013 Standout
Iron-Deficiency Anemia
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus
1999
Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).
1994
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Challenges in the development of magnetic particles for therapeutic applications
2008
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Advanced Glycosylation End Products Up-Regulate Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein-Related Protein 2) in Human Fibroblasts: A Potential Mechanism for Expansion of Extracellular Matrix in Diabetes Mellitus*
2001
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
2004
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
2010
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction
2004
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Meta-analysis: Antibiotics for Prophylaxis against Hemodialysis Catheter–Related Infections
2008
Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes
2003
Works of Jerry Yee being referenced
Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens
2004
Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis
2000
Cyclic Stretching of Mesangial Cells Up-Regulates Intercellular Adhesion Molecule-1 and Leukocyte Adherence
2001
Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysis
2007
Risks associated with renal dysfunction in patients in the coronary care unit
2000
The Independent Association of Renal Dysfunction and Arrhythmias in Critically Ill Patients
2002
Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary report
2003
Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis
1999
What Is So Bad About a Hemoglobin Level of 12 to 13 g/dL for Chronic Kidney Disease Patients Anyway?
2009
Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
2001
Effects of long-term elevated glucose on collagen formation by mesangial cells
2007
Chronic Kidney Disease Awareness Among Individuals with Clinical Markers of Kidney Dysfunction
2011
Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
2010
Considerations in the Critically Ill ESRD Patient
2012
Comparison of Low-Dose Gentamicin With Minocycline as Catheter Lock Solutions in the Prevention of Catheter-Related Bacteremia
2006
Iron sucrose: The oldest iron therapy becomes new
2002
Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease
2002
Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.
1996
Tubulointerstitial injury following glomerulonephritis.
1991